StockWatch
·
Pharmaceuticals
Shareholding12 Jun 2026, 05:41 pm

Sudhir Sethi Acquires 0.005% Stake in Beryl Drugs

AI Summary

Sudhir Sethi, the main promoter of Beryl Drugs Ltd, has acquired 30 equity shares, representing 0.005% of the total share capital. This acquisition, made through market transactions, increases his total holding to 504,169 shares, or 9.915% of the company's total voting capital. The transaction occurred on June 10, 2026.

Key Highlights

  • Promoter Sudhir Sethi acquired 30 shares.
  • Holding increased by 0.005% to 9.915%.
  • Acquisition made via market transactions.
  • Total shares held now stand at 504,169.